Literature DB >> 19910194

Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial.

C Tinterri1, W Gatzemeier, V Zanini, L Regolo, C Pedrazzoli, E Rondini, C Amanti, G Gentile, M Taffurelli, P Fenaroli, C Tondini, G Sacchetto, P Sismondi, R Murgo, M Orlandi, E Cianchetti, C Andreoli.   

Abstract

Breast conserving therapy (BCT) including postoperative irradiation of the remaining breast tissue is generally accepted as the best treatment for the majority of patients with early-stage breast cancer. The question is whether there is a necessity for irradiating all patients. Between 2001 and 2005, 749 women aged 55-75 years with infiltrating breast carcinoma were randomly assigned to breast conservative surgery, with or without radiotherapy (RT), to evaluate the incidence of in-breast recurrence (IBR). After 5 years of median follow-up, the cumulative incidence of IBR was 2.5% in the surgery-only arm and 0.7% in the surgery plus RT arm. There are no differences in terms of overall survival and distant disease-free survival. The preliminary evaluation suggests that breast irradiation after conservative surgery can be avoided without exposing these patients to an increased risk of distant-disease recurrence. Prolonged follow-up will further clarify the possible risks and late sequelae potentially induced by breast RT.

Entities:  

Mesh:

Year:  2009        PMID: 19910194     DOI: 10.1016/j.breast.2009.09.013

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  17 in total

Review 1.  Radiotherapy issues in elderly breast cancer patients.

Authors:  Ian Kunkler
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

2.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Authors:  Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

3.  Older patients with breast cancer: is there bias in the treatment they receive?

Authors:  Christos Markopoulos; Willemien van de Water
Journal:  Ther Adv Med Oncol       Date:  2012-11       Impact factor: 8.168

Review 4.  Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology).

Authors:  Isabella Palumbo; Simona Borghesi; Fabiana Gregucci; Sara Falivene; Antonella Fontana; Cynthia Aristei; Antonella Ciabattoni
Journal:  J Geriatr Oncol       Date:  2021-05-18       Impact factor: 3.599

5.  Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.

Authors:  Kathryn R Tringale; Elizabeth R Berger; Varadan Sevilimedu; Hannah Y Wen; Erin F Gillespie; Boris A Mueller; Beryl McCormick; Amy J Xu; John J Cuaron; Oren Cahlon; Atif J Khan; Simon N Powell; Monica Morrow; Alexandra S Heerdt; Lior Z Braunstein
Journal:  Cancer       Date:  2021-01-26       Impact factor: 6.921

6.  DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.

Authors:  F Sedlmayer; M-L Sautter-Bihl; W Budach; J Dunst; G Fastner; P Feyer; R Fietkau; W Haase; W Harms; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-10       Impact factor: 3.621

7.  The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials.

Authors:  Christiane Matuschek; Edwin Bölke; Jan Haussmann; Svjetlana Mohrmann; Carolin Nestle-Krämling; Peter Arne Gerber; Stefanie Corradini; Klaus Orth; Kai Kammers; Wilfried Budach
Journal:  Radiat Oncol       Date:  2017-03-23       Impact factor: 3.481

8.  Breast cancer: from "maximum tolerable" to "minimum effective" treatment.

Authors:  Umberto Veronesi; Vaia Stafyla; Alberto Luini; Paolo Veronesi
Journal:  Front Oncol       Date:  2012-10-08       Impact factor: 6.244

9.  Do all patients require radiotherapy after breast-conserving surgery?

Authors:  Anita R Skandarajah; G Bruce Mann
Journal:  Cancers (Basel)       Date:  2010-04-28       Impact factor: 6.639

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.